Meet new CFD instrument on Moderna Inc. securities, is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based on messenger RNA (mRNA). Moderna's technology platform inserts synthetic nucleoside-modified mRNA (modRNA) into human cells. This mRNA then reprograms the cells to prompt immune responses. It is a novel technique, abandoned by other manufacturers because of the side effects of repeatedly inserting mRNA into cells by way of lipid nanoparticles, which were found by the other manufacturers to become cytotoxic. Find MRNA at the trading platform in CFD on the NASDAQ group. Watch trading specifications before making trades. We wish you successful trading!